Home
People

Neuro Pioneers
on a Quest to Cure 

A deeply passionate, richly diverse, and collaborative team pioneering the discovery and development of effective precision medicines that will alter the trajectory of neurodegenerative diseases.

LEADERSHIP TEAM

Kasper Roet

PhD
Founder, Chief Executive Officer​

Vikas Sharma

PhD
Chief Business Officer

Dan Elbaum

PhD
Chief Scientific Officer

Hagen Cramer

PhD
Chief Technology Officer

Chris Thomajan

Chief Financial Officer
Board of Directors

Anne C. Whitaker

Chair

Laia Crespo

PhD
Sanofi Ventures

Luc Dochez

PharmD
DROIA Ventures

Johannes Fruehauf

MD
Mission BioCapital

Michael Hutton

PhD
Eli Lilly

Cillian King

PhD
EQT Life Sciences

Kasper Roet

PhD
Founder, Chief Executive Officer​

Amy W. Schulman

Polaris Partners​
Scientific Advisory Board

Sudir Agrawal

PhD, FRSC
Professor, University of Massachusetts Medical School

Kevin Eggan

PhD ​
Founder Group Vice President, Head of Research and Early Development, BioMarin Pharmaceutical

Michelle L. Hastings

PhD
Professor and Director, Center for Genetic Diseases, Chicago Medical School

Matthew C. Kiernan

PhD, DSc, FRACP, FAHMS
Professor, University of Sydney

Christopher Shaw

MD. PhD
Physician Scientist, King’s College

Bernhardt L. Trout

PhD
Professor, MIT

Brian J. Wainger

MD, PhD
Physician Scientist, Harvard Medical School and the Massachusetts General Hospital

Clifford Woolf

MD, PhD
Founder, Director, Boston Children’s Hospital and Harvard Stem Cell Institute
Clinical Advisory Board

Ammar Al-Chalabi

MB, ChB, PhD

Merit Cudkowicz

MD, MSc

Dame Pamela J. Shaw

DBE, MBBS, MD, FRCP, FMedSci, FAAN, FANA, FAAS

Philip Van Damme

MD, PhD ​

Leonard van den Berg

MD, PhD

DISCOVER

Join our World-Class
Pioneering Team

Learn More

Explore More

Latest Press Releases